PROCEPT BioRobotics Corporation

NasdaqGM:PRCT 주식 보고서

시가총액: US$4.8b

PROCEPT BioRobotics 관리

관리 기준 확인 3/4

PROCEPT BioRobotics CEO는 Reza Zadno, Feb2020 에 임명되었습니다 의 임기는 4.75 년입니다. 총 연간 보상은 $ 6.09M, 10.1% 로 구성됩니다. 10.1% 급여 및 89.9% 보너스(회사 주식 및 옵션 포함). 는 $ 12.53M 가치에 해당하는 회사 주식의 0.26% 직접 소유합니다. 12.53M. 경영진과 이사회의 평균 재임 기간은 각각 4.8 년과 3.4 년입니다.

주요 정보

Reza Zadno

최고 경영자

US$6.1m

총 보상

CEO 급여 비율10.1%
CEO 임기4.8yrs
CEO 소유권0.3%
경영진 평균 재임 기간4.8yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Recent updates

Earnings Update: Here's Why Analysts Just Lifted Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$102

Oct 31
Earnings Update: Here's Why Analysts Just Lifted Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$102

Procept BioRobotics: New Hydros Aquablation System To Fuel Next Leg Of Growth

Sep 12

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 27

Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 28%

Aug 25
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 28%

Here's What Analysts Are Forecasting For PROCEPT BioRobotics Corporation (NASDAQ:PRCT) After Its Second-Quarter Results

Aug 04
Here's What Analysts Are Forecasting For PROCEPT BioRobotics Corporation (NASDAQ:PRCT) After Its Second-Quarter Results

PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S Is Still On The Mark Following 37% Share Price Bounce

May 21
PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S Is Still On The Mark Following 37% Share Price Bounce

The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

Apr 05
The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These Results

Mar 01
US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These Results

Despite Lacking Profits PROCEPT BioRobotics (NASDAQ:PRCT) Seems To Be On Top Of Its Debt

Feb 07
Despite Lacking Profits PROCEPT BioRobotics (NASDAQ:PRCT) Seems To Be On Top Of Its Debt

Market Participants Recognise PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Revenues Pushing Shares 26% Higher

Dec 14
Market Participants Recognise PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Revenues Pushing Shares 26% Higher

Is There An Opportunity With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) 43% Undervaluation?

Feb 27
Is There An Opportunity With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) 43% Undervaluation?

Procept Biorobotics announces $52M debt refinancing

Oct 10

Providence announces national contract for PROCEPT Biorobotics Aquabeam Systems

Sep 19

Procept BioRobotics Has Resources To Ramp Up Commercialization

Sep 01

Procept: Leveraging A Novel Water-Based System For Enlarged Prostate Treatment

May 26

Need To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues

May 10
Need To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues

CEO 보상 분석

Reza Zadno 의 보수는 PROCEPT BioRobotics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$100m

Jun 30 2024n/an/a

-US$104m

Mar 31 2024n/an/a

-US$103m

Dec 31 2023US$6mUS$613k

-US$106m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$105m

Mar 31 2023n/an/a

-US$98m

Dec 31 2022US$4mUS$575k

-US$87m

Sep 30 2022n/an/a

-US$77m

Jun 30 2022n/an/a

-US$69m

Mar 31 2022n/an/a

-US$64m

Dec 31 2021US$1mUS$490k

-US$60m

Sep 30 2021n/an/a

-US$57m

Jun 30 2021n/an/a

-US$55m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020US$4mUS$435k

-US$53m

보상 대 시장: Reza 의 총 보상 ($USD 6.09M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 7.91M ).

보상과 수익: 회사가 수익성이 없는 동안 Reza 의 보상이 증가했습니다.

CEO

Reza Zadno (69 yo)

4.8yrs

테뉴어

US$6,088,813

보상

Dr. Reza Zadno, Ph D., has been the President, Chief Executive Officer and Director at Procept Biorobotics Corporation since February 2020. Dr. Zadno served as the Chief Executive Officer at Avedro, Inc. f...

리더십 팀

이름위치테뉴어보상소유권
Reza Zadno
President4.8yrsUS$6.09m0.26%
$ 12.5m
Kevin Waters
Executive VP & CFO6.1yrsUS$2.67m0.11%
$ 5.3m
Alaleh Nouri
EVP, Chief Legal Officer & Corporate Secretary6.3yrsUS$2.19m0.031%
$ 1.5m
Hisham Shiblaq
Executive VP & Chief Commercial Officer5.7yrsUS$2.63m0.014%
$ 686.2k
Mohan Sancheti
Senior Vice President of Operationsno data데이터 없음데이터 없음
Barry Templin
Executive VP of Technology & Clinical Developmentless than a year데이터 없음데이터 없음
Matthew Bacso
Vice President of Investor Relationsno data데이터 없음데이터 없음
Stacey Porter
Chief People Officerless than a year데이터 없음데이터 없음
Bijesh Chandran
Senior Vice President of Regulatory Affairs & Quality Assurance2.8yrs데이터 없음데이터 없음

4.8yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: PRCT 의 관리팀은 경험 ( 4.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Reza Zadno
President4.8yrsUS$6.09m0.26%
$ 12.5m
Thomas Prescott
Chairperson of the Boardless than a year데이터 없음데이터 없음
Frederic Moll
Independent Director13.3yrsUS$277.64k1.49%
$ 71.9m
Taylor Harris
Independent Director3.9yrsUS$254.92k0.24%
$ 11.7m
Larry Wood
Independent Directorless than a year데이터 없음데이터 없음
Elisabeth Sandoval-Little
Independent Director3.1yrsUS$242.16k0.015%
$ 711.7k
Mary Garrett
Independent Director2.9yrsUS$244.92k0.017%
$ 820.0k
Antal Desai
Independent Director9.4yrsUS$247.42k0.31%
$ 15.1m
Amy Dodrill
Independent Director3.4yrsUS$252.42k0.0087%
$ 419.1k

3.4yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: PRCT 의 이사회는 경험(평균 재직 기간 3.4 년)으로 간주됩니다.